Technological survey on LIMS and ELN in Life Sciences - Biogenouest

More documents

Recommendations

Info

The LIMS market is reaching a consolidation stage: there has been recently a strongmerger and acquisition activity and niche suppliers were acquired by large and wellestablishedcompanies such as Abbott, Perkin Elmer and Thermo Fischer (seeFigure 8).Abbott Perkin (LABWORKS) Thermo (WatsonLIMS) STARLIMS (123 M$, 2010) CambridgeSoft (220M$, 2011) ArtusLab (?, 2011) Labtronics (ELN, 2011) GeoSpizza (LIMS, 2011) Accelrys InnaPhase (26M$, 2004) LMS inc (11M$, 2003) Symyx (186M$, 2010) Contur (13M$, 2011) MDL Informations Systems (2007) Figure 8 - Fusion and acquisition of niche solutions by major actorsSupplier interviews The field-based research phase (Phase 2) started with 8 phone interviews ofLIMS/ELN suppliers:- Thermo Fisher- Perkin Elmer- Agilebio (LabCollector)- Loc@soft- Stratocore (PPMS)- SPC consulting (2 contacts)- OVUM (consulting firm)The objective of the interviews was to identify the solutions currently available and/orimplemented in Life Sciences and understand if the solutions are different accordingto segment/customer type.The interviews brought common conclusions- The solutions implemented have a common platform, which is adapted throughspecific modules to the client’s needs- The client segmentation is done based on funding capacity and usageThe segmentation based on funding capacity is as follows:- Big Pharma- Small/medium Pharma- Small/medium Biotechs- Academics- Clusters (combining Pharma, Biotechs, academics)14
Usage of ELN and LIMS also depends on the needs: R&D or quality. LIMS is mostlyimplemented for QA/QC management purposes, as ELN is most suited for R&D.Structure type, size, organization and amount of data generated are also consideredin the segmentation but the data management platform is basically equivalent beforecustomization to match specific needs (different modules). For example, web-basedsolutions, such as Contur (Thermo Fisher), Labcollector (Agilebio) and PPMS(Stratocore) are more adapted to academics and small Biotechs but all thementioned solutions need to be customized to meet specific needs.According to suppliers, ELN and LIMS are fast growing markets. Three majorsuppliers lead the market: Perkin Elmer, Thermo Fisher and Abbott, with PerkinElmer owning 30% of the global LIMS market. The major suppliers are UK and USbased companies and the adoption process is faster in UK and US.French suppliers offer niche solutions such as Stratocore (positioned on thetechnological core facility segment) and AgileBio (flexible solution adapted toacademics and small Biotechs). The ELN market is still emerging, growing faster inindustry than academics/Biotechs since it is difficult to implement a solution withoutdedicated and qualified resources. The pharmaceutical industry has the biggestmarket share due to the high amount of data generated and the regulatoryrequirements (FDA regulations, such as 21CFR).The key benefits expected from user are different between industry and academia:- Increase productivity in industry (Perkin Elmer claims +20% by scientist)- Intellectual property protection and data record in academiaHowever there are common benefits such as increased quality, traceability,efficiency, keep track of successful but also unsuccessful studies (avoid « Redo »),avoid loss of data (especially in academic laboratories where turnover is high), beable to prove data during a publication submission (ELN is ISO9001 compliant) andcompliance with regulations (ISO9001, 21CFR, etc.).User typology for the <strong>survey</strong> Overall a total of 62 respondents were contacted during the study (see Figure 9):Corporategroups, 6%Biotechs,32%Academic lab& corefacilities, 61%Figure 9 – Segmentation of <strong>survey</strong>ed respondents15
Page 1 and 2: Technological <str
Page 3 and 4: ) Implemented quality standards
Page 5 and 6: Survey background 1 -‐ Backg
Page 7 and 8: Computer data management system
Page 9 and 10: The implementation of data manageme
Page 11 and 12: While the vast majority of companie
Page 13: Figure 7 - LIMS and ELN solutions13
Page 17 and 18: - Head of platform- Head of resourc
Page 19 and 20: - Need for innovation- Design of ne
Page 21 and 22: ) Implemented quality standards
Page 23 and 24: Nb. of respondents (N=30)3025201510
Page 25 and 26: The perceived benefits of implement
Page 27 and 28: Nb. of respondents (N=17)Surveyed r
Page 29 and 30: As indicated by the suppliers, the
Page 31 and 32: 2 -‐ Quality system The <str
Page 33 and 34: customized solutions since they are
Page 35 and 36: Appendix 1: Online surve
Page 37 and 38: □□□□Pas de besoin actuellem
Page 39 and 40: □□□□□Avantage concurrenti
Page 49 and 50: Appendix 3: Surveyed contact li
Page 51 and 52: Appendix 4: Peer recommendations
Page 53: B$: Billion DollarsCRO: Contract Re

Technological survey on LIMS and ELN in Life Sciences - Biogenouest

Create successful ePaper yourself

Delete template?

Save as template?